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The O antigen (Oag) component of lipopolysaccharide (LPS) is a major S. 42 
flexneri virulence determinant. Oag is polymerised by WzySf, and its modal 43 
chain length is determined by WzzSf and WzzpHS2. Site-directed mutagenesis 44 
was performed on wzySf in pWaldo-wzySf-TEV-GFP to alter Arg residues in 45 
WzySf’s two large periplasmic loops (PL) (PL3 and PL5). Analysis of the LPS 46 
profiles conferred by mutated WzySf proteins in the wzySf deficient (Δwzy) 47 
strain identified residues that affect WzySf activity. The importance of the 48 
guanidium group of the Arg residues was investigated by altering the Arg 49 
residues to Lys and Glu, which generated WzySf mutants conferring altered 50 
LPS Oag modal chain lengths. The dependence of these WzySf mutants on 51 
WzzSf was investigated by expressing them in a wzySf and wzzSf deficient 52 
(Δwzy Δwzz) strain. Comparison of the LPS profiles identified a role for the 53 
Arg residues in the association of WzySf and WzzSf during Oag 54 
polymerisation. Colicin E2 and bacteriophage Sf6c susceptibility supported 55 
this conclusion. Comparison of the expression levels of different mutant 56 
WzySf-GFP proteins with the wild type (WT) WzySf-GFP showed that certain 57 
Arg residues affected production levels of WzySf in a WzzSf dependent 58 
manner. To our knowledge, this is the first report of S. flexneri WzySf mutants 59 
having an effect on LPS Oag modal chain length, and identified functionally 60 






Shigella flexneri is the main causative agent for the disease shigellosis or 66 
bacterial dysentery. 125 million shigellosis cases occur annually in Asia, with 67 
approximately 14000 fatalities (Bardhan et al., 2010). The O antigen (Oag) 68 
component of the lipopolysaccharide (LPS) of Shigella flexneri plays an 69 
important role in the pathogenesis of the bacteria. Oag is composed of 70 
oligosaccharide repeat units (RUs) or O units. Oag is linked to the 71 
hydrophobic anchor of the LPS (Lipid A) by the non-repeating oligosaccharide 72 
domain known as the core sugar region (Raetz & Whitfield, 2002; Sperandeo 73 
et al., 2009). The complete LPS structure with Oag chains is termed smooth 74 
LPS (S-LPS). However, the LPS structure devoid of Oag is termed rough LPS 75 
(R-LPS), and LPS with only one O unit is termed semi-rough LPS (SR-LPS) 76 
(Morona et al., 1994).   77 
 78 
 Oag is the serotype determinant and also the protective antigen of the 79 
bacteria (Jennison & Verma, 2004; Stagg et al., 2009; Sun et al., 2013). 80 
Depending on the composition of Oag S. flexneri is divided into 17 serotypes 81 
(Sun et al., 2013). Except serotype 6, all the serotypes share a basic 82 
polysaccharide backbone containing three L-rhamnoses (Rha), and one N-83 
acetylglucosamine (GlcNAc). This basic Oag structure is known as serotype 84 
Y. The differences between the serotypes are conferred by addition of 85 
glucosyl, O-acetyl, or phosphoethanolamine (PEtN) functional groups by 86 
various linkages to the sugars of the basic tetrasaccharide RU (Allison & 87 
Verma, 2000; Sun et al., 2012; Wang et al., 2010). Oag restricts the 88 
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accessibility of the colicin to their outer membrane (OM) receptor protein 89 
(Tran et al., 2014; van der Ley et al., 1986). In addition, the bacteriophage Sf6 90 
uses Oag as a receptor and forms plaques on serotype Y and X strains 91 
(Lindberg et al., 1978). 92 
 93 
S. flexneri LPS biosynthesis occurs mainly by two separate pathways: 94 
1) lipid A and core biosynthesis and 2) Oag biosynthesis. Oag biosynthesis 95 
occurs on either side of the inner membrane (IM) and it is mediated by the 96 
Wzy-dependent pathway (Allison & Verma, 2000; Morona et al., 1995). S. 97 
flexneri Oag biosynthesis starts by the transfer of N-acetylglucosamine 98 
phosphate (GlcNAc-1-P) from an uridine diphosphate-GlcNAc (UDP-GlcNAc) 99 
to undecaprenol phosphate (Und-P) at the cytoplasmic side of the IM by 100 
WecA (Guo et al., 2008; Liu et al., 1996; Wang et al., 2010). Then the 101 
rhamnosyl transferases (RfbG and RfbF) add sequential Rha residues to the 102 
GlcNAc to form the O unit (McKinney et al., 2002; Morona et al., 1994). 103 
Translocation of the O unit to the periplasmic side is mediated by the protein 104 
Wzx. At the periplasmic side O units are polymerised by Wzy to form the Oag. 105 
The chain length of the Oag is regulated by Wzz (Daniels et al., 1998; Morona 106 
et al., 1994). Finally, the Oag chains are transferred to the core-lipid A by the 107 
ligase WaaL. The Lpt proteins (Lpt A - G) facilitate the transport of the LPS 108 
from the IM to the OM (Ruiz et al., 2008; Sperandeo et al., 2009). 109 
 110 
 S. flexneri Wzy (WzySf) is a 43.7 kDa hydrophobic integral membrane 111 
protein. It has 12 transmembrane (TM) segments and two large periplasmic 112 
(PL) domains (PL3 and PL5) (Daniels et al., 1998; Morona et al., 1994). 113 
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Previously we were able to identify some of the key functional amino acid 114 
residues of WzySf, providing insight into WzySf structure and function (Nath et 115 
al., 2015). WzySf has a RX15G motif in both of the PL3 and PL5 starting from 116 
R164 in PL3 and R289 in PL5. It also has several Arg residues between these 117 
two motifs. In the Pseudomonas aeruginosa Wzy (WzyPa), it was found that 118 
the PL3 and PL5 have RX10G motifs, which are important for Oag 119 
polymerisation activity. There are several Arg residues within these two 120 
motifs, which play an important role in the Oag polymerisation (Islam et al., 121 
2011). However, there is little sequence identity between WzySf and WzyPa. 122 
Islam et al. performed extensive work on WzyPa and conducted a 123 
“jackhammer” search to find the homologues of WzyPa. However, their results 124 
showed that WzyPa is not related to Wzy from Enterobacteriaceae (Islam et 125 
al., 2013). 126 
 127 
 The modal length of the Oag chain is regulated by Wzz proteins, 128 
members of the polysaccharide co-polymerase (PCP) family (Morona et al., 129 
2000). S. flexneri 2a has S-LPS with two types of modal chain length: short 130 
(S) type (11 - 17 Oag RUs) and very long (VL) type (>90 Oag RUs), and the 131 
S-type and VL-type Oag chain lengths are determined by WzzSf and WzzpHS2, 132 
respectively (Morona et al., 2003; Morona & Van Den Bosch, 2003). 133 
Woodward et al. proposed that Wzy and Wzz have an interaction during Oag 134 
biosynthesis and according to them these two proteins are enough to shape 135 
the Oag modal chain length (Woodward et al., 2010).  Several other research 136 
groups have also suggested that Wzz and Wzy interact during Oag 137 
biosynthesis (Islam et al., 2013; Marolda et al., 2006; Taylor et al., 2013; Tocilj 138 
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et al., 2008). However, there is a lack of direct evidence on the association of 139 
Wzz and Wzy in Oag polymerisation and chain length control. Recently, we 140 
identified the WzzSf dependent WzySf mutants, and showed that WzzSf has a 141 
novel role in the stability of WzySf and also in the Oag polymerisation activity 142 
of WzySf (Nath et al., 2015).  143 
 144 
 In this study we performed site-directed mutagenesis on Arg residues in 145 
the PL3 and PL5 of WzySf and identified key Arg residues (R164, R250, R258, 146 
and R289) important for WzySf polymerisation activity and Oag modal chain 147 
length control. Several Arg residues have a role in the association of WzzSf 148 
and WzySf during Oag biosynthesis and the WzzSf dependent stability of 149 
WzySf.  150 
 151 
Methods 152 
Bacterial strains and plasmids 153 
The strains and plasmids used in this study are shown in Table 1.  154 
 155 
Growth media and growth conditions 156 
The growth media used were lysogeny broth (LB) broth (10 g/liter tryptone, 5 157 
g/liter yeast extract, 5 g/liter NaCl) and LB agar (LB broth, 15 g/liter bacto 158 
agar). 159 
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Strains were grown in LB broth with aeration for 18 h at 37C. 18 h 160 
cultures were diluted 1/20 into fresh LB broth and grown to mid-exponential 161 
phase (optical density at 600 nm [OD600] of 0.4 - 0.6). To suppress protein 162 
expression growth medium was supplemented with 0.2% (w/v) glucose where 163 
required. Cells were centrifuged (2200 x g, SIGMA 3K15 table top centrifuge, 164 
10 min, 4°C) and washed twice with LB broth to remove glucose. To induce 165 
protein expression 0.2% (w/v) L-Arabinose was added to cultures and grown 166 
for 20 h at 20C. Antibiotics were added as required to the media at the 167 
following final concentrations: 50 g kanamycin (Km) ml-1, and 25 g 168 
chloramphenicol (Cm) ml-1.  169 
 170 
LPS method  171 
LPS was prepared as described previously (Nath et al., 2015). Cells (1X109) 172 
were harvested and resuspended in lysing buffer and incubated with 173 
proteinase K for approximately 16 h. The LPS samples were then separated 174 
by SDS-PAGE on 15% (w/v) gels for 16.5 h at 12 mA. Silver nitrate was used 175 
to stain the gels and finally the gels were developed with formaldehyde 176 
(Murray et al., 2003). 177 
 178 
Site-directed mutagenesis  179 
Site-directed mutagenesis on wzySf in plasmid pRMPN1 (Nath et al., 2015; 180 
Waldo et al., 1999) was performed using the QuikChange Lightning Site-181 
Directed Mutagenesis Kit (Catalog # 210518, Stratagene) following the 182 
manufacturer’s instructions. Mutagenised plasmids were transformed into 183 
 9 
XL10-Gold. Plasmids were isolated and the mutations within the coding region 184 
were identified by DNA sequencing (AGRF, Adelaide, Australia). The 185 
oligonucleotide primers used for site-directed mutagenesis are listed in 186 
Supplementary Table S1. 187 
 188 
Detection of WzySf expression in S. flexneri  189 
Procedure of WzySf-GFP expression in S. flexneri has been described 190 
previously (Nath et al., 2015). Cells were harvested from the 50 ml L-191 
arabinose induced culture. Then the cell pellet was resuspended in 4 ml 192 
sonication buffer (20 mM Tris-HCl, 150 mM NaCl, pH 7.5) and lysed by 193 
sonication. Cell debris was removed by centrifugation (2200 X g, SIGMA 194 
3K15 table top centrifuge, 10 min, 4 °C). The whole membrane (WM) fraction 195 
was isolated by ultracentrifugation (Beckman Coulter Optima L-100 XP bench 196 
top ultracentrifuge, 126 000 X g, 1 h, 4 °C). The WM fraction was 197 
resuspended in PBS and then solubilized in Buffer A (200 mM Tris-HCl [pH 198 
8.8], 20% [v/v] glycerol, 5 mM EDTA [pH 8.0], 0.02% [w/v] bromophenol blue, 199 
4% [w/v] SDS, and 0.05 M DTT). Solubilized WM fractions (from 3 X 108 cells) 200 
were electrophoresed on SDS-15% (w/v) PAGE gels. Gels were rinsed with 201 
distilled water, and fluorescent imaging of the gels was performed to detect 202 
wild type (WT) and mutant WzySf-GFP protein expression with a Bio-Rad Gel 203 
Doc XR + System using Image Lab software (excitation at 485 nm and 204 
emission at 512 nm). Loading was checked by staining the gels with 205 
Coomassie Blue R-250. The intensity of WT and mutant WzySf-GFP 206 
expression in control and mutant strains was measured by Fiji image 207 
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processing package (http://fiji.sc/Fiji) and the percent relative WzySf-GFP 208 
intensity for each mutant was measured by comparing with WT WzySf-GFP 209 
intensity in the control strain PNRM13.  210 
 211 
Colicin sensitivity assay 212 
For the colicin sensitivity assay, His6-colicin E2 (ColE2) with an initial 213 
concentration of 1 mg ml-1 was used (Tran et al., 2014). The procedure of 214 
ColE2 spot assay has been described previously (Nath et al., 2015). The 215 
ColE2 spot assay was performed for all strains expressing WT and mutant 216 
WzySf-GFP and the other control strains. The end point of the killing zones of 217 
mutant strains was compared with the controls.  218 
 219 
Bacteriophage sensitivity assay 220 
The procedures of phage propagation and phage stock preparation have 221 
been described previously (Mavris et al., 1997; Morona et al., 1994). The 222 
procedure of bacteriophage Sf6c sensitivity assay has been described 223 
previously (Nath et al., 2015). Phage sensitivity of all strains expressing 224 
mutant WzySf-GFP was compared with the strains expressing WT WzySf-GFP 225 






Site-directed mutagenesis of Arg residues in PL3 and PL5 of WzySf  231 
In a previous study on WzySf, random mutagenesis failed to detect any 232 
functional residue in PL5 (Nath et al., 2015). However, Islam et al. found that 233 
the Arg residues in the two principal PLs (PL3 and PL5) of WzyPa are 234 
important for Oag polymerisation activity (Islam et al., 2011). The RX10G 235 
motifs of the PL3 and PL5 of WzyPa (Islam et al., 2011) are absent in WzySf. 236 
However, both PL3 and PL5 of WzySf contained RX15G motifs (starting from 237 
R164 in PL3 and R289 in PL5) (Fig. 1) (Table S2), and there are also several 238 
Arg residues between these two motifs. So, site-directed mutagenesis on 239 
wzySf in the pRMPN1 was performed to change the basic polar and positively 240 
charged Arg residues (R164, R250, R258, R278, and R289) to Ala (nonpolar 241 
and neutral substitution), Lys (basic polar and positively charged substitution), 242 
and Glu (acidic polar and negatively charged substitution) (Fig. 1) (See 243 
Methods). Mutated plasmids were transformed into PNRM6 (RMM109 244 
[pAC/pBADT7-1]) (∆wzy) (Table 1) for phenotypic analysis (Nath et al., 2015).  245 
 246 
LPS phenotype conferred by the WzySf mutants 247 
LPS profiling by SDS-PAGE and silver staining were used to detect the effect 248 
of the WzySf mutations on the LPS Oag polymerisation. Mutants were initially 249 
grouped into five different phenotypic classes (A, B, C, D, and F) (Fig. 2 and 250 
Table 2) by comparing the LPS profiles of the mutant strains with the WT 251 
positive control PNRM13. Based on the number of Oag RUs in the Oag modal 252 
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chain length (WzzSf regulated S-type) the class A mutants were further 253 
subdivided into subclasses A1, A2, and A3 (Table 2). The mutational 254 
alteration R164A resulted in complete loss of Oag polymerisation activity (SR-255 
LPS or class C) (Fig. 2, lane 3), R164K resulted in an S-LPS with reduced 256 
Oag polymerisation (< 30 Oag RUs) and lacking modal chain length control 257 
(class F LPS) (Fig. 2, lane 5; and Table 2), and R164E resulted in complete 258 
loss of polymerisation activity (SR-LPS or class C) (Fig. 2, lane 7), similar to 259 
R164A. Mutational alterations R250A and R250E resulted in decreased Oag 260 
polymerisation activity (LPS with < 11 Oag RUs or class B) (Fig. 2, lanes 9 261 
and 13). However, the mutational alteration R250K resulted in an S-LPS with 262 
reduced Oag polymerisation, and the modal chain length was reduced to 8-11 263 
RUs (Subclass A1) (Fig. 2, lane 11; and Table 2) and was just detectable 264 
compared to the positive control (PNRM13). Similar to mutational alterations 265 
of R164, both R258A and R258E resulted in an SR-LPS (class C) (Fig. 2, 266 
lanes 15 and 19). The mutational alteration R258K resulted in an S-LPS with 267 
reduced polymerisation and the modal chain length was reduced to 9-14 RUs 268 
(Subclass A2) (Fig. 2, lane 17; and Table 2). For the residue R278, the 269 
mutational alterations investigated had no detectable effect on the LPS 270 
profiles, and all strains had LPS profiles (class D) similar to the relevant WT 271 
control (PNRM13) (Fig. 2, lanes 21, 23, and 25). For residue R289, mutational 272 
alteration R289A resulted in a class A LPS profile and the LPS Oag modal 273 
chain length of this strain was similar to PNRM13 (Fig. 2, lane 27; and Table 274 
2) but lacked S-LPS with Oag >22 RUs; the LPS profile of this strain was 275 
further classified as subclass A3. The mutational alteration R289E resulted in 276 
a class A LPS profile with an Oag modal length of 8-14 RUs (Subclass A2) 277 
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(Fig. 2, lane 31; and Table 2) that was shorter than that seen in the positive 278 
control (PNRM13). The mutational alteration R289K resulted in class D LPS 279 
profile (Fig. 2, lane 29). So, except R278 the other Arg residues (R164, R250, 280 
R258, and R289) were found to be important for WzySf Oag polymerisation 281 
activity. For the positions R164, R1250, and R258 the guanidium functional 282 
group of Arg is important as Lys substitution resulted in partial WzySf activity. 283 
In particular, certain substitutions [R164K (no modal chain length), R250K (8 - 284 
11 RUs), R258K (9 - 14 RUs), and R289E (8 - 14 RUs)] (Table 2) resulted in 285 
an S-LPS with a decreased Oag modal chain length. 286 
 287 
WzzSf dependence and polymerisation activity 288 
Previously we found an effect of WzzSf on WzySf Oag polymerisation activity 289 
(Nath et al., 2015). We investigated the dependence of the mutant WzySf 290 
proteins generated above on WzzSf for their Oag polymerisation activity. All 291 
the plasmids encoding the mutated WzySf proteins were transformed into the 292 
strain PNRNM126 (RMA4337 [pAC/pBADT7]), which has both wzySf and 293 
wzzSf genes inactivated. LPS profiles conferred in the PNRM126 background 294 
(∆wzy ∆wzz) were directly compared with the LPS profiles conferred in the 295 
PNRM6 background (∆wzy). The positive control strain in the ∆wzy ∆wzz 296 
background, PNRM134 (PNRM126 [pRMPN1]) (Table 1) had a class E LPS 297 
profile (S-LPS without Oag modal length control) (Fig.2, lane 2; and Table 2). 298 
WzySf with Ala, Lys, and Glu substitutions of R164 resulted in similar LPS 299 
profiles both in the ∆wzy and ∆wzy ∆wzz backgrounds (Fig. 2, lanes 3 - 4, 5 - 300 
6, and 7 - 8). The WzySf mutations R250A, R250E, and R258A resulted in 301 
 14 
similar LPS profiles both in the ∆wzy and ∆wzy ∆wzz backgrounds (Fig. 2, 302 
lanes 9 - 10, 13 - 14, and 15 - 16). Interestingly, WzyR250K resulted in LPS 303 
with greatly reduced Oag polymerisation (class B) in the ∆wzy ∆wzz 304 
background (Fig. 2, lane 12) compared to the ∆wzy background (class A1) 305 
(Fig. 2, lane 11). In contrast, WzyR258E resulted in dramatic increase in Oag 306 
polymerisation in the ∆wzy ∆wzz background (class E) compared to the ∆wzy 307 
background (Class C) (Fig. 2, lanes 19 - 20). However, WzyR258K resulted in 308 
a class F LPS profile (Fig. 2, lane 18) in the ∆wzy ∆wzz background. For 309 
residue R278, all changes resulted in class E LPS profiles (Fig. 2, lanes 22, 310 
24, and 26) in the ∆wzy ∆wzz backgrounds, as expected. WzyR289A and 311 
WzyR289E resulted in class F LPS profiles (Fig. 2, lanes 28 and 32) in the 312 
∆wzy ∆wzz background. In contrast, the ∆wzy ∆wzz strain with WzyR289K 313 
resulted in an S-LPS lacking Oag modal chain length control (class E LPS 314 
profile) (Fig. 2, lane 30) and was similar to the control PNRM134 (Fig. 2, lane 315 
2). Hence, some of the WzySf mutants showed remarkably different LPS 316 
profiles in the absence of WzzSf, indicating WzzSf dependence of their Oag 317 
polymerisation activity as previously reported for other WzySf mutants (Nath et 318 
al., 2015). 319 
 320 
ColE2 sensitivity of strains with WzySf mutants  321 
The ColE2 sensitivity of the strains expressing WzySf mutants was 322 
investigated to verify the LPS profiles determined by SDS-PAGE and silver 323 
staining. The ColE2 sensitivity (summarized in Table 3) was determined by 324 
spot testing as described in the Methods.  325 
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As expected, the negative control strains RMM109, PNRM6, PNRM11, 326 
RMA4337, and PNRM126 had the highest sensitivity to ColE2 (killing zone at 327 
a dilution of 1/256) (Table 3). The WT strain PE638 and the positive control 328 
with WzySf-GFP in the ∆wzy ∆wzz background (PNRM134) were resistant to 329 
the highest concentration of ColE2 used. However, the positive control with 330 
WzySf-GFP in the ∆wzy background (PNRM13) showed a killing zone at a 331 
dilution of 1/2 (Table 3) as previously reported (Nath et al., 2015).  Strains 332 
with a class A LPS profile in the ∆wzy background was sensitive to ColE2. 333 
Among them the strain with decreased Oag modal chain length (subclass A1) 334 
were relatively more sensitive to ColE2 (killing zone at 1/64). However, the 335 
strains with more Oag (subclass A2 and A3) showed a killing zone at 1/32. 336 
Strains with a class B LPS profiles (both ∆wzy and ∆wzy ∆wzz backgrounds) 337 
showed a killing zone at 1/128.  As expected the strains with class C LPS 338 
profiles (SR-LPS) (both ∆wzy and ∆wzy ∆wzz backgrounds) showed the 339 
highest sensitivity to ColE2 (killing zone at 1/256), and their sensitivity to 340 
ColE2 was similar to the negative control strains. Strains with WT like class D 341 
LPS profiles (∆wzy background) were more resistant to ColE2 (killing zone R - 342 
1/4). Among them the ∆wzy strains with WzyR278A and WzyR278E showed 343 
ColE2 sensitivity similar to the WT strain PE638, greater than the relevant 344 
positive control PNRM13. Strains with a class E LPS profile (∆wzy ∆wzz 345 
background) showed greater sensitivity to ColE2 (killing zone 1/16 - 1/64) 346 
compared to the relevant positive control PNRM134, suggesting that they had 347 
a decreased level of Oag polymerisation. Strains with a class F LPS profile in 348 
the ∆wzy and ∆wzy ∆wzz backgrounds were also very sensitive to ColE2, and 349 
showed a killing zone at 1/64 or 1/128. Hence, as reported previously (Nath et 350 
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al., 2015), the ColE2 assay detects subtle differences in LPS Oag chain 351 
length and density, which are consequences of difference in Oag 352 
polymerisation. 353 
 354 
Bacteriophage Sf6c sensitivity of strains with WzySf mutants  355 
The bacteriophage Sf6c sensitivity of the strains expressing WzySf mutants 356 
was investigated to further verify the LPS profiles determined by SDS-PAGE 357 
and silver staining. The bacteriophage Sf6c sensitivity of the strains 358 
(summarized in Table 3), carrying mutated wzySf plasmids were determined 359 
by spot testing (see Methods).  360 
 361 
The negative control strains (with an SR-LPS profile) RMM109, 362 
PNRM6, PNRM11, RMA4337, and PNRM126 were all resistant to the highest 363 
concentration of bacteriophage Sf6c tested, as expected. The WT strain 364 
PE638 and the positive control with WzySf-GFP in the ∆wzy ∆wzz background 365 
(PNRM134) showed the highest sensitivity to bacteriophage Sf6c and showed 366 
plaques at 10-6. However, for the positive control with WzySf-GFP in the ∆wzy 367 
background (PNRM13) the phage showed plaques at 10-5 (Table 3) (Nath et 368 
al., 2015). Strains with class A, B, C, and F LPS profiles in the ∆wzy and ∆wzy 369 
∆wzz backgrounds were resistant to the highest concentration of 370 
bacteriophage Sf6c tested, similar to the negative control strains. However, 371 
the strains with class D LPS profiles were very sensitive to bacteriophage 372 
Sf6c (plaques at 10-5 or 10-6). Among them the ∆wzy strain with WzyR278A 373 
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and WzyR278E showed the highest sensitivity to Sf6c and their sensitivity to 374 
bacteriophage Sf6c was greater than the relevant positive control PNRM13, 375 
and similar to the positive control with WzySf-GFP in the ∆wzy ∆wzz 376 
background (PNRM134). The strains with class E LPS profile were relatively 377 
more resistant to bacteriophage Sf6c (resistant or plaques at 10-1 or N) 378 
compared to the relevant positive control PNRM134, indicating a difference in 379 
Oag density. Similar to our previous data (Nath et al., 2015), the 380 
bacteriophage Sf6c assays above indicated that the degree of Oag 381 
polymerisation and density is correlated with bacteriophage Sf6c sensitivity. 382 
 383 
Protein expression levels of the WzySf mutants 384 
We measured parental and mutant WzySf-GFP expression in the ∆wzy and 385 
∆wzy ∆wzz backgrounds by in-gel fluorescence and then calculated the % 386 
relative WzySf-GFP expression of all the mutant strains by comparing 387 
expression levels of different WzySf-GFP mutants with the WzySf-GFP in 388 
PNRM13 (100%) (See Methods). The positive control in the ∆wzy ∆wzz 389 
background (PNRM134) had WzySf-GFP expression level (relative WzySf-GFP 390 
level 17%) less than the positive control in the ∆wzy background (PNRM13) 391 
(Fig. 3a, 3b, and 3c, lanes 1 and 2, Table 3).  392 
 393 
Both in the ∆wzy and ∆wzy ∆wzz backgrounds, with some exceptions, 394 
most of the WzySf mutants were expressed at a level less than 100%. The 395 
∆wzy strain with WzyR164A had expression of 132% (Fig. 3a, lane 3; and 396 
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Table 3) but the ∆wzy ∆wzz strain with WzyR164A had a relative WzySf-GFP 397 
level of 87% (Fig. 3a, lane 4; and Table 3). Both of these strains had an SR-398 
LPS profile. The ∆wzy ∆wzz strain with WzyR258A had an SR-LPS but the 399 
relative WzySf-GFP level was 200% (Fig. 3a, lane 8; and Table 3), which is 400 
double than the WzySf-GFP level in PNRM13. The ∆wzy strain with 401 
WzyR258A had a relative WzySf-GFP level of 62% (Fig. 3a, lane 7; and Table 402 
3). Both the ∆wzy and ∆wzy ∆wzz strains with WzyR164K expressed at a 403 
level more than 100% (120% and 125%, respectively) (Fig. 3b, lanes 3 and 4; 404 
and Table 3). In the ∆wzy ∆wzz background both WzyR250K and WzyR258K 405 
were expressed at a very low level (11% and 0.02%, respectively) (Fig. 3b, 406 
lane 8; Fig. 3C lane 4; and Table 3). However, in the ∆wzy strain, WzyR250K 407 
and WzyR258K were expressed at high levels (142% and 104%, respectively) 408 
(Fig. 3b, lane 7; Fig. 3c, lane 3; and Table 3). Interestingly, the ∆wzy and 409 
∆wzy ∆wzz strains with WzyR250E had class B LPS profile but their relative 410 
WzySf-GFP levels were 133% and 143%, respectively (Fig. 3b, lanes 9 and 411 
10; and Table 3). The ∆wzy strain with WzyR278E and the ∆wzy ∆wzz strain 412 
with WzyR289E had very high relative WzySf-GFP levels (135% and 140%, 413 
respectively) (Fig. 3c, lanes 9 and 14; and Table 3). However, the ∆wzy ∆wzz 414 
strain with WzyR278E and the ∆wzy strain with WzyR289E had low relative 415 
WzySf-GFP levels (28% and 21% respectively) (Fig. 3c, lanes 10 and 13; and 416 
Table 3). The comparison of % WzySf-GFP expression levels of different 417 
mutants in the ∆wzy and ∆wzy ∆wzz backgrounds indicates that the 418 




Wzy proteins are essential for the synthesis of many Oags that are virulence 422 
determinants of the Gram negative bacteria. WzySf has two large PLs (PL3 423 
and PL5) (Daniels et al., 1998). During mutational characterisation of WzySf 424 
we found that the amino acid P165 in PL3 is important for the stabilization of 425 
WzySf through interaction with WzzSf (Nath et al., 2015). However, through 426 
random mutagenesis we were unable to identify any other amino acid 427 
residues in PL3 and PL5 important for the Oag polymerisation activity and 428 
association with WzzSf. In this study site-directed mutagenesis of these two 429 
loops generated mutants that were then characterised based on their LPS 430 
profiles, ColE2 and bacteriophage Sf6c sensitivities, and WzySf-GFP 431 
expression to reveal novel mutant phenotypes.   432 
 433 
Islam et al. showed that the mutational alteration of Arg to Ala in the 434 
WzyPa PL3 and PL5 within the two RX10G motifs resulted in either complete or 435 
partial loss of Oag polymerisation activity and alterations of some of the Arg 436 
residues to Lys resulted in LPS profiles similar to their Ala substitution (Islam 437 
et al., 2011). In S. flexneri, site-directed mutation of R164, R250, R258, and 438 
R289 to Ala also resulted in the complete or partial loss of Oag polymerisation 439 
activity in the Δwzy background. The Arg residues in PL3 and PL5 were 440 
changed to Ala, Lys, and Glu to determine the importance of the guanidium 441 
functional group of Arg at these positions. In the ∆wzy background Ala, Lys, 442 
and Glu substitutions of R164, R250, and R258 resulted in complete or partial 443 
loss of polymerisation (Fig. 2). Lys substitutions at these three positions 444 
 20 
resulted in S-LPS with reduced degree of Oag polymerisation (class F or 445 
class A) but with different Oag modal chain lengths [Class F (without modal 446 
chain), class A1 (8-11 RUs), class A2 (9-14 or 8-14 RUs)] (Fig. 2) compared 447 
to the relevant positive control PNRM13. These WzySf mutants (WzyR164K, 448 
WzyR250K, and WzyR258K) resulted in LPS with different Oag modal chain 449 
length. So, guanidium functional group of Arg residues at these positions had 450 
position specific effect on Oag polymerisation and modal chain length control. 451 
This effect has not been reported previously for S. flexneri wzySf mutations. 452 
 453 
Previously, we found Wzz-dependent WzySf mutants (Nath et al., 454 
2015). In this study we found several new examples of WzzSf-dependent 455 
WzySf mutants. The ∆wzy ∆wzz strain with WzyR250K had decreased Oag 456 
polymerisation in the absence of WzzSf and the ∆wzy ∆wzz strain with 457 
WzyR258E had increased Oag polymerisation in the absence of WzzSf, even 458 
though WzyR258E was inactive in the ∆wzy background (Fig. 2).  Hence, 459 
residues R250 and R258 have roles in the association of WzySf and WzzSf 460 
during the WzySf mediated Oag polymerisation. These and our previous 461 
results (Nath et al., 2015) suggest that the interactions between WzySf and 462 
WzzSf are complex. 463 
 464 
The ColE2 and bacteriophage Sf6c sensitivity assays supported the 465 
LPS profiles of the WzySf mutants. We found that the WzySf mutants with 466 
shorter Oag chains in the LPS were more sensitive to ColE2 (Table 3), 467 
consistent with our previous results (Nath et al., 2015). Here we found that in 468 
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the ∆wzy background the strains with different Oag modal chain lengths 469 
showed different sensitivities to ColE2, with an increase in resistance 470 
correlated with an increase in Oag RUs in the LPS Oag modal chain. Strains 471 
with class A, B, and C LPS profiles in the ∆wzy background were resistant to 472 
bacteriophage Sf6c (Table 3). This result was consistent with our previous 473 
findings (Nath et al., 2015) that bacteriophage Sf6c only infects if the S-LPS 474 
has WT or nearly WT level of Oag polymerisation. In our previous study we 475 
found that while the strains with class D LPS had S-LPS profiles very similar 476 
to the relevant positive control strain (PNRM13), they were more resistant to 477 
ColE2 and more sensitive to bacteriophage Sf6c compared to PNRM13 (Nath 478 
et al., 2015). Here the ∆wzy strain with WzyR278A and WzyR278E showed a 479 
similar phenotype (Fig. 3, and Table 3).  480 
 481 
Previously we found that WzzSf is not only associated with Oag modal 482 
chain length control but also affects the level of WzySf (Nath et al., 2015). In 483 
the ∆wzy and ∆wzy ∆wzz backgrounds most of the mutant WzySf-GFP 484 
proteins had expression levels less than the WzySf-GFP in PNRM13 (Table 485 
3). However, in the ∆wzy background the expression level of WzyR164A and 486 
in the ∆wzy ∆wzz background the expression level of WzyR258A was greater 487 
than the WzySf-GFP in PNRM13 (Table 3). We speculate that residues R164 488 
and R258 are important for the stabilization of WzySf through a potential 489 
interaction with WzzSf. The ∆wzy strain with WzyR164A and the ∆wzy ∆wzz 490 
strain with WzyR258A had SR-LPS profiles (Fig. 2). So, the absence of Oag 491 
polymerisation activity is not due to a lack of protein expression.  492 
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The ∆wzy and ∆wzy ∆wzz strains with WzyR164K and WzyR250E had 493 
a higher level of expression compared to WzySf-GFP in PNRM13 but the LPS 494 
profiles of these strains indicated that the mutant proteins had decreased Oag 495 
polymerisation activity compared to the relevant positive controls (Table 3 and 496 
Fig. 3). So, these mutations in some way stabilized the protein, both in the 497 
presence and absence of WzzSf.  498 
 499 
The ∆wzy strain with WzyR250K and WzyR258K had high level of 500 
expression but ∆wzy ∆wzz strain with WzyR250K and WzyR258K had very 501 
low level of expression (Fig. 3 and Table 3), suggesting that the presence of 502 
WzzSf stabilizes these WzySf mutants. The ∆wzy strain with WzyR250K had 503 
LPS with an increased degree of Oag polymerisation compared to ∆wzy ∆wzz 504 
strain with WzyR250K, and the ∆wzy and the ∆wzy ∆wzz strains with 505 
WzyR258K had nearly similar LPS profiles (class A2 and class F) but the 506 
∆wzy strain with WzyR258K had LPS with an Oag modal chain length of 9-14 507 
RUs (Fig. 2). However, all these strains had LPS with a decreased level of 508 
Oag polymerisation compared to the relevant positive controls. These results 509 
again suggest that Oag polymerisation activity of WzySf is not correlated with 510 
the expression level of the protein. The ∆wzy strain with WzyR278E and the 511 
∆wzy ∆wzz strain with WzyR289E (Fig. 3 and Table 3) had higher level of 512 
expression compared to the WzySf-GFP in PNRM13. Hence residues R278 513 
and R289 are also important for the stabilization of WzySf through a potential 514 
interaction with WzzSf.  515 
 516 
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According to the model proposed by Islam et al. at a physiological pH, 517 
WzyPa PL3 and PL5 possess a net positive charge and a net negative charge, 518 
respectively (Islam et al., 2011). PL3, the “capture arm”, catches incoming 519 
negatively charged Oag subunit for subsequent transfer to PL5, which acts as 520 
a “retention arm”. It involves a relatively transient interaction with the Oag and 521 
is responsible for the constant binding and release of growing Oag chain. 522 
They proposed that these characteristics of PLs support their roles in the 523 
“catch- and-release” mechanism during Oag polymerisation by Wzy. PL3 and 524 
PL5 of WzyPa have a high level of sequence equivalence (Islam et al., 2011). 525 
Zhao et al. found that Escherichia coli O86 Wzy (WzyEc) has a different 526 
number of TM and different amino acid sequence compared to WzyPa (Zhao et 527 
al., 2014) but the pI values of PL3 and PL4 (the two largest PLs) of WzyEc are 528 
equivalent to PL3 and PL5 of WzyPa. At a physiological pH, PL3 and PL4 of 529 
WzyEc possess a net positive charge and a net negative charge, respectively, 530 
which led them to conclude that WzyEc follows a similar catalytic mechanism 531 
to WzyPa (Zhao et al., 2014). For WzySf, we found that the pI values of PL3 532 
and Pl5 were 4.65 and 5.09, respectively, using the ExPASy pI calculator 533 
(http://web.expasy.org/compute_pi/). Hence, at a physiological pH both the 534 
PL3 and PL5 of WzySf possess net negative charge. While the P. aeruginosa 535 
PAO1 Oag contains negatively charged uronic acid (Knirel et al., 2006) S. 536 
flexneri Oag is neutral. So, the charge property of the substrate for WzySf is 537 
different from the WzyPa. PL3 and PL5 of WzySf also lack shared conserved 538 
residues. Polymerisation of the Oag of all the serotypes of S. flexneri is 539 
conducted by a single type of WzySf, which defines the flexibility of substrate 540 
recruitment of WzySf. The RX10G motifs of WzyPa contain several other Arg 541 
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residues within the motifs (R176, R180 in PL3 and R291 in PL5) (Islam et al., 542 
2011; Islam et al., 2013) but the WzySf had no Arg residues within the RX15G 543 
motifs of PL3 and PL5 (Fig. 1). The RX10G motifs of WzyPa starts in the PL 544 
and ends in the PL (Islam et al., 2011; Islam et al., 2013) but the RX15G motifs 545 
of WzySf starts in the PL and ends in the TM (Fig. 1).  Nevertheless, we found 546 
that the Arg residues in the PL3 and PL5 have roles in Oag polymerisation, 547 
association with WzzSf, and WzySf expression level. Hence, a modified version 548 
of  “catch-and-release” (Islam et al., 2011) mechanism may exist for S. 549 
flexneri Oag synthesis.  550 
 551 
In conclusion, we identified key Arg residues in PL3 and PL5 of WzySf 552 
that are important for the polymerisation activity, association with WzzSf during 553 
polymerisation, and WzzSf dependent stabilization of the protein. The WzySf 554 
mutants that confer altered Oag modal chain length suggest that WzzSf 555 
functions to alter the activity of WzySf and this is mimicked by certain 556 
mutational alterations, leading to change in the Oag modal chain length. The 557 
current findings extended the previous finding (Nath et al., 2015). and we 558 
conclude that a wider region (PL 2, 3, 5, 6 and TM 5, 8) is involved in the Oag 559 
polymerisation activity and potential interaction with WzzSf. We hypothesize 560 
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TABLE 1. Bacterial strains and plasmids used in this study 740 
Strains or Plasmids Characteristics* Reference 
Strains 
S. flexneri  
PE638 S. flexneri Y rpoB (Rifr) (Morona et al., 1994) 
RMM109 PE638Δwzy, Rifr (Morona et al., 1994) 
RMA4337 RMM109 Δwzz (Rifr, Tetr) (Nath et al., 2015) 
PNRM6 RMM109 [pAC/pBADT7-1] (Nath et al., 2015) 
PNRM13 PNRM6 [pRMPN1] (Nath et al., 2015) 
PNRM16 PNRM6 [pRMPN2] This study 
PNRM17 PNRM6 [pRMPN3] This study 
PNRM18 PNRM6 [pRMPN4] This study 
PNRM19 PNRM6 [pRMPN5] This study 
PNRM20 PNRM6 [pRMPN6] This study 
PNRM126 RMA4337 [pAC/pBADT7-1] (Nath et al., 2015) 
PNRM134 PNRM126 [pRMPN1] (Nath et al., 2015) 
PMRM127 PNRM126 [pRMPN2] This study 
PMRM128 PNRM126 [pRMPN3] This study 
PMRM129 PNRM126 [pRMPN5] This study 
PMRM130 PNRM126 [pRMPN6] This study 
PMRM153 PNRM126 [pRMPN4] This study 
PNRM190 PNRM6 [pRMPN27] This study 
PNRM192 PNRM6 [pRMPN28] This study 
PNRM194 PNRM6 [pRMPN29] This study 
PNRM196 PNRM6 [pRMPN30] This study 
PNRM198 PNRM6 [pRMPN31] This study 
PNRM216 PNRM6 [pRMPN32] This study 
PNRM218 PNRM6 [pRMPN33] This study 
PNRM220 PNRM6 [pRMPN34] This study 
PNRM222 PNRM6 [pRMPN36] This study 
PNRM232 PNRM6 [pRMPN35] This study 
E.coli strains 
XL10-G Tet rΔ(mcrA)183 Δ(mcrCB-
hsdSMR-mrr)173 endA1 supE44 
thi-1 recA1 gyrA96 relA1 lac [F´ 





Table 1: cont.   
Strains or Plasmids Characteristics* Reference 
Plasmids   
pAC/pBADT7-1 Source of T7 RNA polymerase; 
Cmr 
(McKinney et al., 2002) 
pWaldo-TEV-GFP Cloning vector with GFP tag; Kmr (Waldo et al., 1999) 
pRMPN1 pWaldo-wzySF-GFP; Km
r (Nath et al., 2015) 
pRMPN2 pRMPN1 with WzyR164A  This study 
pRMPN3 pRMPN1 with WzyR250A  This study 
pRMPN4 pRMPN1 with WzyR258A  This study 
pRMPN5 pRMPN1 with WzyR278A  This study 
pRMPN6 pRMPN1 with WzyR289A  This study 
pRMPN27 pRMPN1 with WzyR164K  This study 
pRMPN28 pRMPN1 with WzyR250K  This study 
pRMPN29 pRMPN1 with WzyR258K  This study 
pRMPN30 pRMPN1 with WzyR278K  This study 
pRMPN31 pRMPN1 with WzyR289K  This study 
pRMPN32 pRMPN1 with WzyR164E  This study 
pRMPN33 pRMPN1 with WzyR250E  This study 
pRMPN34 pRMPN1 with WzyR258E  This study 
pRMPN35 pRMPN1 with WzyR278E  This study 
pRMPN36 pRMPN1 with WzyR289E  This study 
 741 
* Rifr, rifampicin resistant; Kmr, kanamycin resistant; Cmr, chloramphenicol 742 








TABLE 2. LPS profiles of different WzySf mutant phenotypic classes 750 
WzySf mutant Class LPS profile 
A1 S-LPS with reduced Oag polymerisation, and the 
modal chain length was reduced to 8-11 RUs 
A2 S-LPS with reduced polymerisation and the modal 
chain length was reduced to 9-14 or 8-14 Oag RUs 
A3 S-LPS with reduced polymerisation (< 22 Oag RUs) 
and the modal chain length was similar to the WT 
control (PNRM13)  
B LPS with few Oag RUs (< 11 Oag RUs) 
C SR-LPS 
D LPS profile similar to the WT control PNRM13 
E S-LPS lacking Oag modal chain length control 
F S-LPS with reduced Oag polymerisation and lacking 















TABLE 3. ColE2 and bacteriophage Sf6c sensitivities, and WzySf-GFP expression levels 764 
    Sensitivity
* 
 
  Mutant class  ColE2  
 
Sf6c Relative WzySf-GFP (%) 
Strain or 





















Strains           
RMM109 wzySf mutant    1/256 - R - - - 
PE638 Wild type    R - 10
-6 
- - - 
PNRM13 Positive control    1/2 - 10
-5 
- 100 - 
PNRM6 Negative control    1/256 - R - - - 
PNRM11 Negative control    1/256 - R - - - 
RMA4337 wzySf and wzzSf 
mutant 
   - 1/256 - R
 
- - 
PNRM126 Negative control    - 1/256 - R - - 
PNRM134 Positive control    - R - 10
-6 
- 17 
Mutants           
R164A   C  C PL3 1/256 1/256 R R 132 87 
R250A   B  B PL5 1/128 1/128 R R 81 55 
R258A   C  C PL5 1/256 1/256 R R 62 200 
R278A   D  E PL5 R 1/16 10
-6
 N 18 14 
R289A   A3  F PL5 1/32 1/128 R R 14 82 
R164K   F  F PL3 1/64 1/128 R R 120 125 
R250K   A1  B PL5 1/64 1/128 R R 142 11 
R258K   A2  F PL5 1/32 1/64 N R 104 0.02 




 46 36 
R289K   D  E PL5 1/4  1/64 10
-5
 N 60 38 
R164E   C  C PL3 1/256  1/256 R R 80 99 
R250E   B  B PL5 1/128  1/128 R R 133 143 
R258E   C  E PL5 1/256  1/64 R R 16 38 
R278E   D  E PL5 R 1/64 10
-6
 R 135 28 
R289E   A2  F PL5 1/32 1/64 N R 21 140 
 765 
#
PL - Periplasmic loop (See Fig. 1). 766 
* 





Fig. 1. Location of the mutations constructed in this study on the 771 
topology map of WzySf.  772 
Mutational alterations were indicated by arrows on the WzySf topology map 773 
[adapted from (Daniels et al., 1998)]. The position of the periplasmic loops 774 
(PL) 1-5, transmembrane regions (TM) 1-12, and cytoplasmic loops (CL) 1-5 775 
are indicated. The residues mutated in this study (dark shaded circles) were 776 
located in the PL3 and 5. The position of RX15G motifs (light shaded circles) in 777 





Fig. 2. Comparison of the LPS phenotype conferred by the WzySf 782 
mutants expressed in the ∆wzy and ∆wzy ∆wzz backgrounds.  783 
The plasmids encoded mutant and WT WzySf proteins were expressed in 784 
PNRM6 (RMM109 [pAC/pBADT7-1]) and PNRM126 (RMA4337 785 
[pAC/pBADT7-1]). Strains were grown and induced as described in the 786 
Methods. LPS samples were electrophoresed on a SDS-15% (w/v) PAGE gel 787 
and silver stained (See Methods). Strains were grouped into various mutant 788 
classes (A, B, C, D, E, and F) and subclasses (A1, A2, and A3) based on their 789 
LPS profiles as described in the text (Table 2).   790 
Lanes 1 - 2 are: 1. PNRM13 (PNRM6 [pRMPN1]), and 2. PNRM134 791 
(PNRM126 [pRMPN1]). Lanes 3 - 32 are the Δwzy or Δwzy Δwzz strains with 792 
plasmids encoding mutated WzySf proteins. The WzySf mutants in each lane 793 
are as follows: 3. R164A (Δwzy), 4. R164A (Δwzy Δwzz), 5. R164K (Δwzy), 6. 794 
R164K (Δwzy Δwzz), 7. R164E (Δwzy), 8. R164E (Δwzy Δwzz), 9. R250A 795 
(Δwzy), 10. R250A (Δwzy Δwzz), 11. R250K (Δwzy), 12. R250K (Δwzy Δwzz), 796 
 39 
13. R250E (Δwzy), 14. R250E (Δwzy Δwzz), 15. R258A (Δwzy), 16. R258A 797 
(Δwzy Δwzz), 17. R258K (Δwzy), 18. R258K (Δwzy Δwzz), 19. R258E (Δwzy), 798 
20. R258E (Δwzy Δwzz), 21. R278A (Δwzy), 22. R278A (Δwzy Δwzz), 23. 799 
R278K (Δwzy), 24. R278K (Δwzy Δwzz), 25. R278E (Δwzy), 26. R278E (Δwzy 800 
Δwzz), 27. R289A (Δwzy), 28. R289A (Δwzy Δwzz), 29. R289K (Δwzy), 30. 801 
R289K (Δwzy Δwzz), 31. R289E (Δwzy), 32. R289E (Δwzy Δwzz). 802 
The position of R-LPS is indicated. The numbers on the left and right indicate 803 
the Oag RUs. Letters (A1, A2, A3, B, C, D, E, and F) at the bottom indicate 804 















Fig. 3. Protein expression level of the WzySf-GFP mutants.  819 
The strains were grown in LB and induced as described in the Methods. In-gel 820 
fluorescence samples were prepared from the mutants in the Δwzy and Δwzy 821 
Δwzz backgrounds, and electrophoresed on SDS 15% (w/v) PAGE gels (See 822 
Methods).  823 
a. Strains in lane 1-2 are as follows: 1. PNRM13 (PNRM6 [pRMPN1]), 2. 824 
PNRM134 (PNRM126 [pRMPN1]). Lanes 3- 12 are the Δwzy or Δwzy Δwzz 825 
strains expressing mutated WzySf-GFP proteins. The WzySf mutants in each 826 
lane are as follows: 3. R264A (Δwzy), 4. R164A (Δwzy Δwzz), 5. R250 827 
(Δwzy), 6. R250 (Δwzy Δwzz), 7. R258A (Δwzy), 8. R258A (Δwzy Δwzz), 9. 828 
R278A (Δwzy), 10. R278A (Δwzy Δwzz), 11. R289A (Δwzy), 12. R289A (Δwzy 829 
Δwzz).  830 
 41 
b. Strains in lane 1 - 2 are as follows: 1. PNRM13, 2. PNRM134. Lanes 3- 10 831 
are the Δwzy or Δwzy Δwzz strains expressing mutated WzySf-GFP proteins. 832 
The WzySf mutants in each lane are as follows: 3. R164K (Δwzy), 4. R164K 833 
(Δwzy Δwzz), 5. R164E (Δwzy), 6. R164E (Δwzy Δwzz), 7. R250K (Δwzy), 8. 834 
R250K (Δwzy Δwzz), 9. R250E (Δwzy), 10. R250E (Δwzy Δwzz). 835 
c. Strains in lane 1 - 2 are as follows: 1. PNRM13, 2. PNRM134. Lanes 3- 14 836 
are the Δwzy or Δwzy Δwzz strains expressing mutated WzySf-GFP proteins. 837 
The WzySf mutants in each lane are as follows: 3. R258K (Δwzy), 4. R258K 838 
(Δwzy Δwzz), 5. R258E (Δwzy), 6. R258E (Δwzy Δwzz), 7. R278K (Δwzy), 8. 839 
R278K (Δwzy Δwzz), 9. R278E (Δwzy), 10. R278E (Δwzy Δwzz), 11. R289K 840 
(Δwzy), 12. R289K (Δwzy Δwzz), 13. R298E (Δwzy), 14. R289E (Δwzy Δwzz). 841 
In each panel, the relative WzySf-GFP level of all the mutants were measured 842 
by considering the WzySf-GFP in PNRM13 in lane 1 as 100%. Letters (A1, A2, 843 
A3, B, C, D, E, and F) at the bottom indicate the mutant class (Table 2). 844 
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